(Q36659068)

15 August 2017

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century (English)

1 reference

15 August 2017

1 reference

7

Beat Thürlimann

1 reference

15 August 2017

8

John Collins

1 reference

15 August 2017

11

Aron Goldhirsch

1 reference

15 August 2017

Olivia Pagani

1

1 reference

15 August 2017

Karen N Price

2

1 reference

15 August 2017

Richard D Gelber

3

1 reference

15 August 2017

Monica Castiglione-Gertsch

4

1 reference

15 August 2017

Stig B Holmberg

5

1 reference

15 August 2017

Jurij Lindtner

6

1 reference

15 August 2017

Martin F Fey

9

1 reference

15 August 2017

Alan S Coates

10

1 reference

15 August 2017

International Breast Cancer Study Group (IBCSG)

12

1 reference

15 August 2017

language of work or name

English

0 references

publication date

10 January 2009

1 reference

Breast Cancer Research and Treatment

15 August 2017

1 reference

15 August 2017

117

1 reference

15 August 2017

2

1 reference

15 August 2017

319-324

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-008-0282-0

15 August 2017

0 references

cites work

New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Chemotherapy: what progress in the last 5 years?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Annual hazard rates of recurrence for breast cancer after primary therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Challenges associated with longitudinal survivorship research: attrition and a novel approach of reenrollment in a 6-year follow-up study of older breast cancer survivors.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

First--select the target: better choice of adjuvant treatments for breast cancer patients.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Reliability of steroid hormone receptor assays: an international study

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3589101

Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19137426

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19137426

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19137426

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-008-0282-0

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

19137426

1 reference